- Home
- LQDT vs AUTL Comparison
LQDT vs AUTL Comparison
Compare LQDT & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LQDT
- AUTL
- Stock Information
- Founded
- LQDT 1999
- AUTL 2014
- Country
- LQDT United States
- AUTL United Kingdom
- Employees
- LQDT N/A
- AUTL N/A
- Industry
- LQDT Catalog/Specialty Distribution
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LQDT Consumer Discretionary
- AUTL Health Care
- Exchange
- LQDT Nasdaq
- AUTL Nasdaq
- Market Cap
- LQDT 773.6M
- AUTL 625.4M
- IPO Year
- LQDT 2006
- AUTL 2018
- Fundamental
- Price
- LQDT $23.85
- AUTL $2.33
- Analyst Decision
- LQDT Strong Buy
- AUTL Strong Buy
- Analyst Count
- LQDT 2
- AUTL 5
- Target Price
- LQDT $38.50
- AUTL $9.32
- AVG Volume (30 Days)
- LQDT 271.5K
- AUTL 2.5M
- Earning Date
- LQDT 08-07-2025
- AUTL 08-07-2025
- Dividend Yield
- LQDT N/A
- AUTL N/A
- EPS Growth
- LQDT 23.09
- AUTL N/A
- EPS
- LQDT 0.79
- AUTL N/A
- Revenue
- LQDT $439,246,000.00
- AUTL $9,011,000.00
- Revenue This Year
- LQDT $35.02
- AUTL $461.76
- Revenue Next Year
- LQDT $9.90
- AUTL $112.66
- P/E Ratio
- LQDT $29.72
- AUTL N/A
- Revenue Growth
- LQDT 35.78
- AUTL N/A
- 52 Week Low
- LQDT $19.31
- AUTL $1.11
- 52 Week High
- LQDT $39.72
- AUTL $5.00
- Technical
- Relative Strength Index (RSI)
- LQDT 39.20
- AUTL 64.81
- Support Level
- LQDT $23.25
- AUTL $1.98
- Resistance Level
- LQDT $24.09
- AUTL $2.35
- Average True Range (ATR)
- LQDT 0.65
- AUTL 0.12
- MACD
- LQDT 0.15
- AUTL -0.01
- Stochastic Oscillator
- LQDT 33.64
- AUTL 72.15
About LQDT Liquidity Services Inc.
Liquidity Services Inc is an online auction marketplace. It manages and sells inventory and equipment for business and government clients by operating a network of e-commerce marketplaces that enable buyers and sellers to transact in an efficient, automated environment offering across different product categories. The company has four reportable segments: GovDeals, Capital Assets Group (CAG), Retail Supply Chain Group (RSCG), and Machinio. It generates majority of its revenue from Retail Supply Chain Group (RSCG) segment which consists of marketplaces that enable corporations located in the United States and Canada to sell excess, returned, and overstocked consumer goods. Geographically, a substantial portion the company's revenue is generated from its business in United States.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.